2hrs. of  COPE ACCREDITED CE          virtual webinar

8:00 am-10:00 pm eastern time

8:00pm-10:00pm:

 Steve Kaufman, OD & Christopher Bair, MD

“Developments in Macular Degeneration Prevention and Treatment”  COPE # 92555-TD

The course will have three parts. The first review evidence for why genetic testing to guide AREDS formulation use can benefit your macular degeneration patients and your practice. The second will review new anti-VEGF medications. Are they worth their high cost? The third will discuss new drugs to treat dry AMD. Do the benefits really outweigh the risks?

10:00pm ADJOURNMENT